Gain-of-function gene variants of PCSK9 occur with familial combined hypercholesterolemia, in which individuals have increases in plasma total cholesterol, ApoB, and/or triglyceride levels, while loss-of-function variants occur with familial hypobetalipoproteinemia-1. This evidence concerns the gene APOB and familial hypobetalipoproteinemia 1.